The novel diagnostic model improves early detection of hepatocellular carcinoma in patients, suggesting enhanced diagnostic accuracy with integrated approaches.
The GALADM model, combining miRNA7 with the GALAD model, surpasses the original GALAD model, enabling early-stage and AFP-negative HCC diagnosis.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: